Product Information
VUITY 1.25% EYE DROP is a brand product labeled by AbbVie Inc., priced at $31.3936 per ML under NDC 00074709804. Its NADAC has been published 219 times since Apr 20, 2022.
The High Outlier badge above means this manufacturer's average price in the Pilocarpine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/mL
Manufacturer
AbbVie Inc.NDC
00074709804
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
PILOCARPINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA214028On Market Since
10/28/2021
Pharmacological Classes
Price Statistics
The NADAC for VUITY 1.25% EYE DROP has been published 219 times since Apr 20, 2022, and over the history we have for it it has risen 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $31.3936 per ML |
|---|---|
| All-time high | $31.3936 (Jun 24, 2026) |
| All-time low | $28.1106 (Dec 20, 2023) |
| 52-week high | $31.3936 |
| 52-week low | $29.5760 |
| Median price | $29.5760 |
| Average price | $29.2134 |
| Largest weekly change | +5.0% (Jan 14, 2026) |
| Weeks tracked | 219 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VUITY 1.25% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for VUITY 1.25% EYE DROP, manufactured by AbbVie Inc., is $31.3936 per ML (NDC 00074709804), effective Jun 24, 2026.
How has the price of VUITY 1.25% EYE DROP changed over time?
Over the history we have for it, the NADAC for VUITY 1.25% EYE DROP has risen 11.0%. It has been tracked across 219 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for VUITY 1.25% EYE DROP?
Since Apr 20, 2022, the NADAC for VUITY 1.25% EYE DROP has ranged from a low of $28.1106 (Dec 20, 2023) to a high of $31.3936 (Jun 24, 2026), with a median of $29.5760 per ML.
Are there cheaper alternatives to VUITY 1.25% EYE DROP?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VUITY 1.25% EYE DROP, is $23.3874 per ML — about 26% below VUITY 1.25% EYE DROP.
Who manufactures VUITY 1.25% EYE DROP?
VUITY 1.25% EYE DROP (NDC 00074709804) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification